by supplychainreport
The health care logistics sector stood out in 2025, attracting attention from major freight operators amid a generally subdued market. High-margin opportunities, resilient demand, and alignment with demographic trends have made this segment increasingly strategic for logistics providers.
Key deals in 2025 included acquisitions of specialized cold-chain, final-mile, and clinical trial logistics operators, enhancing capabilities for pharmaceuticals, medical devices, cell and gene therapies, and specialty pharmacy distribution. These moves allow operators to offer faster transit times, improved shipment visibility, and expanded global networks.
Industry analysts note that the life sciences and health care logistics market is expected to grow significantly, with projections indicating a compound annual growth rate of 7.8–11% through the next decade. Rising demand for specialty pharmacy services, biopharma shipments, and clinical trial logistics is driving investments across Europe, North America, and beyond.
The sector’s resilience and independence from broader freight market fluctuations make it a core focus for major logistics players, with continuous investments in acquisitions, technology, and service expansion expected to sustain growth through 2030.
#HealthCareLogistics #SupplyChainUpdate #ColdChain #LifeSciences #FreightNews
